Javier Ena

7PUBLICATIONS
11CO-AUTHORS
Epidemiological modellingCardiovascular medicine and haematology not elsewhere classifiedMetabolic medicineIntensive careMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2024
Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly.

Javier Ena, Silvena Stanimirova-Nikolova, Maria Iborra-Devesa

|Sep 01, 2022
Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials.

Javier Ena, Victoria Valls

|Aug 26, 2022
High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study.

Juana Carretero-Gómez, Pablo Pérez-Martínez, José Miguel Seguí-Ripoll

|Jan 15, 2021
Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.

María Gómez Antúnez, Antonio Muiño Míguez, Alejandro David Bendala Estrada

|Jan 05, 2021
Evaluation of FilmArray ME panel for the rapid diagnosis of meningitis-encephalitis in emergency departments.

Javier Ena, Raisa Goretti Afonso-Carrillo, Miriam Bou-Collado

|Sep 15, 2020
Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial.

Antonio Perez, Francisco Javier Carrasco-Sánchez, Carlos González

Pageof 2

Frequent Collaborators

2 joint publications

José Miguel Seguí-Ripoll

1 joint publications

Antonio Perez

1 joint publications

Francisco Javier Carrasco-Sánchez

1 joint publications

Mireia Borrell